Page 24 - Markets News

US-Iran talks, oil movement to drive bullion trend next week: Analysts

US-Iran negotiations, crude oil trends and key economic data will shape gold and silver prices in the week ahead

US-Iran talks, crude prices likely to steer stock markets this week

Markets would also track the monsoon trajectory in the country, an analyst said

Mcap of 9 most valued firms jumps ₹2.15 trn, Airtel biggest winner

Reliance Industries remained the most valued domestic firm, followed by HDFC Bank, Bharti Airtel, ICICI Bank, State Bank of India, TCS, Bajaj Finance, Larsen & Toubro, LIC and Hindustan Unilever

Private equity firms tap hot loan market to pay themselves via debt deals

Over the last four weeks alone, ten borrowers have launched more than $3.5 billion of leveraged loans and junk bonds to fund distributions for their owners

Forex reserves fall $10 bn as decline in gold prices drags overall holdings

India's foreign exchange reserves recorded their steepest weekly decline since March, with a sharp fall in gold reserve valuations offsetting gains in foreign currency assets

Zerodha Fund House unveils mutual fund industry's first lifecycle funds

The new funds automatically shift asset allocation towards lower-risk investments as the target year approaches

SC flags 'deep-rooted nexus' between banks, ARCs, borrowers over loans

The apex court expressed concern over alleged deep-discount settlements of stressed loans and sought responses from the Centre, RBI and other stakeholders

Sebi board brings back open-market share buybacks; eases debt listing

The market regulator also cleared a faster approval route for alternative investment funds and aligned norms for securitised debt instruments with RBI rules

Sebi clarifies EPI benefits; Turtlemint Fintech IPO subscribed 45% on Day 1

The market regulator revised commodity margin provisions, cleared SBI Mutual Fund's IPO and oversaw the opening day of Turtlemint Fintech's share sale

Valuation upgrades for Nykaa hinge on sustained margin expansion

Analysts remain positive on Nykaa's growth plans in beauty and fashion, but believe sustained margin expansion will be critical for further valuation rerating

Jio IPO may unlock value and trigger Reliance rerating, say experts

Market participants expect Jio Platforms' IPO to improve valuation discovery, attract investor interest and unlock value for Reliance Industries shareholders

Multiple growth drivers could keep Polycab rally going despite valuations

At current price, company is trading at a steep 47 times its FY27 earnings

Stock Market Close: Sensex tanks 608 pts, Nifty ends at 24,013 on IT sell-off; RIL shares slip 1.2%

Sensex Today | Stock Market Highlights, Friday: Reliance Industries share price settled 1.2 per cent lower at ₹1,312 after Chairman Mukesh Ambani announced Jio Platforms' IPO papers were being filed

Premier Explosives zooms 52% in 1 month; what's behind the rally?

In the past six months, the stock price of the company surged 78 per cent, as compared to 10 per cent decline in the BSE Sensex.

G-sec tax break announcement yet to make an impression on foreign investors

FPIs pull out nearly ₹13,000 crore in June and the rupee continues to be under pressure

Gold may test $4,000 amid strong dollar, hawkish Fed: Mirae Asset ShareKhan

Gold price outlook: In the near term, gold can slide further. A test of support around $4000 is possible, while an extended decline to $3800 cannot be ruled out.

HFCL shares extend rally, hit 5% upper circuit; zoom 250% from 52-week low

HFCL shares have multiplied investor wealth over the past fourt months, surging about 250 per cent from their 52-week low of ₹59.82, touched earlier this year on January 27, 2026

Lubricant stocks: Panama Petrochem, Gandhar Oil soar 18% on huge volumes

Share price of Panama Petrochem zoomed 18% to hit a new high at ₹484.40 on the back of two-fold jump in trading volume on Friday.

JBM Auto shares rise 4% on securing ₹750-cr investment from Motilal Oswal

JBM Auto shares have gained about 55 per cent from their 52-week low of ₹477 apiece, touched earlier this year on March 16, 2026

Patent expiry: A $5 bn opportunity for Indian pharma majors, says report

Lupin, Intas Pharmaceuticals, Sun Pharma, MSN Laboratories, Natco Pharma, Zydus Life Sciences and Dr Reddy's Laboratories are some of the companies, the note said, that could potentially benefit.